Women's Health News

RSS

Zetiq reports self declaration CE mark of conformity for cervical cancer diagnostic kit

Zetiq Technologies Ltd., a subsidiary of Bio-Light Ltd., reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens.

27 Jul 2010

Female sexual dysfunction can affect quality of life: Research

Almost two-thirds of females attending a general urology practice reported that they suffered from sexual dysfunction, according to a paper in the August issue of BJUI. Dysfunction rose with age in all categories except orgasm, with more than half of women aged from 18 to 30 reporting orgasm problems, significantly higher than women aged 31 to 54.

27 Jul 2010

AU leaders summit kicks off, focus on maternal and child health

Heads of state from the African Union (AU) started a three-day meeting in Kampala, Uganda, on Sunday as part of the 15th AU Summit, People's Daily Online reports. Leaders will focus on maternal and child health and will discuss several other issues, including agricultural development, food security, infrastructure development and economic integration (7/26).

27 Jul 2010

Abviva to receive patent for its new Mammastatin technology

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks

27 Jul 2010

Obesity linked to early puberty in girls

A review of more than 100 studies found overweight girls tend to reach puberty earlier than their peers do.

26 Jul 2010

Obesity linked to rising womb cancer in women: Report

According to a new report from the Charity Cancer Research (CCR) in Britain, the number of women with womb cancer or uterine cancer is on the rise and obesity may be a clue to such rise.

26 Jul 2010

CUTCO Cutlery donates over a half million dollars to support Go Red For Women movement

In just over three years, CUTCO Cutlery has donated over a half million dollars to support the American Heart Association's Go Red For Women movement.

26 Jul 2010

Einstein scientists awarded $4.1M to test microbicide Carraguard against HPV

The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard- against the human papillomavirus, which causes cervical cancer. The research will evaluate the efficacy of Carraguard- - a clear gel made from the seaweed derivative carrageenan - in preventing new HPV infections in women.

26 Jul 2010

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

Unigene Laboratories, Inc. today noted that Tarsa Therapeutics has completed patient enrollment in the Phase III ORACAL trial of Tarsa's oral calcitonin product for the treatment of postmenopausal osteoporosis. Unigene licensed the product to Tarsa and owns 26% of the company.

23 Jul 2010

GRB7 gene drives an aggressive form of breast cancer, researchers find

Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis.

23 Jul 2010

GOP questions math of HHS' premium hike estimates; Abortion issue defining implementation

Senate Republican leaders are questioning an estimate by the Department of Health and Human Services that the effect of the new health law on insurance premiums will likely be less than 1 percent, The Hill reports.

23 Jul 2010

China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal Suppositories

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced that the Company has obtained approval from the State Food and Drug Administration in China for the production of Ciclopirox Olamine Vaginal Suppositories.

23 Jul 2010

Choice between late-term abortion or keeping an unhealthy foetus

Most pregnant women whose foetus is proven to have a genetic abnormality choose to have an abortion, but reaching that decision is a painful, exhausting process for most of them. "The women's doubt, pain and sorrow make abortion more moral - in the eyes of society as well as her own," says Sølvi Marie Risøy, a researcher at the Stein Rokkan Centre for Social Studies, University of Bergen.

23 Jul 2010

Health bodies to discuss steps to further reduce mother to child HIV transmission

Transmission of HIV to children before or at birth has dropped dramatically around the country in the last decade since the advent of powerful new therapies. That certainly is true for Florida, where each year, fewer than 10 babies are born with the disease despite the fact that more than 600 HIV-positive women each year, on average, give birth.

23 Jul 2010

Fla. doctors consider cutting ties to AMA; Indiana seeks to get more uninsured covered; LA continues to seek leader for troubled health department

The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.

23 Jul 2010

Waiting times for abortions in New Zealand need to be reduced

Women in New Zealand wait an average of 25 days to get a termination of pregnancy, from the date of their first visit to the doctor. Researchers writing in BioMed Central's open access journal Reproductive Health studied the timeliness of services provided at nine New Zealand clinics, finding that efforts need to be made by clinics and referring doctors to reduce the waiting times.

23 Jul 2010

2010 Life Beyond Cancer Retreat invites applications

The Life Beyond Cancer Foundation is calling for applications from cancer survivors, oncology nurses, social workers, oncologists, and primary care physicians who help diagnose cancer to attend the 2010 Life Beyond Cancer Retreat. The 11th annual retreat, held Nov. 18 – 21 at Lakeway Resort & Spa in Austin, Texas, helps women rekindle their spirits, relax their minds and bodies, and rejuvenate their souls.

23 Jul 2010

African ancestry associated with triple-negative breast cancer: Study

A new study finds that African ancestry is linked to triple-negative breast cancer, a more aggressive type of cancer that has fewer treatment options.Researchers at the University of Michigan Comprehensive Cancer Center found that, among women with breast cancer, 82 percent of African women were triple negative, 26 percent of African-Americans were and 16 percent of white Americans were.

23 Jul 2010

Drugs can save African infants' lives

Researchers at the University of Sydney have found the combined intake of iron-folic acid supplements with World Health Organisation (WHO)-endorsed anti-malarial drugs during pregnancy could reduce early infant mortality in sub-Saharan Africa by a quarter.

22 Jul 2010

Tarsa completes enrollment in Phase III ORACAL trial for postmenopausal osteoporosis

Tarsa Therapeutics, Inc. today announced progress in the ORACAL trial of its oral calcitonin product for the treatment of postmenopausal osteoporosis. The company has completed patient enrollment in this multinational, randomized, double-blind, placebo-controlled Phase III trial designed to enroll approximately 550 patients. In addition, Tarsa announced that the independent Data Monitoring Committee (DMC) for the ORACAL trial has completed two separate safety reviews of patient data and recommended that the trial proceed as planned.

22 Jul 2010

Women's Health News

Zetiq reports self declaration CE mark of conformity for cervical cancer diagnostic kit

Female sexual dysfunction can affect quality of life: Research

AU leaders summit kicks off, focus on maternal and child health

Abviva to receive patent for its new Mammastatin technology

Obesity linked to early puberty in girls

Obesity linked to rising womb cancer in women: Report

CUTCO Cutlery donates over a half million dollars to support Go Red For Women movement

Einstein scientists awarded $4.1M to test microbicide Carraguard against HPV

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

GRB7 gene drives an aggressive form of breast cancer, researchers find

GOP questions math of HHS' premium hike estimates; Abortion issue defining implementation

China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal Suppositories

Choice between late-term abortion or keeping an unhealthy foetus

Health bodies to discuss steps to further reduce mother to child HIV transmission

Fla. doctors consider cutting ties to AMA; Indiana seeks to get more uninsured covered; LA continues to seek leader for troubled health department

Waiting times for abortions in New Zealand need to be reduced

2010 Life Beyond Cancer Retreat invites applications

African ancestry associated with triple-negative breast cancer: Study

Drugs can save African infants' lives

Tarsa completes enrollment in Phase III ORACAL trial for postmenopausal osteoporosis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News